CTKB vs NTRS · rev $92.3M vs P/E 18, rev $2.69B
Cytek Biosciences Inc (CTKB) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Latest reported CTKB revenue for 2026-06-30 was $92.3M. Net income was -$31.0M. CTKB currently screens at market cap $421.8M.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
CTKB currently screens at market cap $421.8M. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the CTKB and NTRS stock pages for the full models.
Not investment advice.